1. Home
  2. AIRS vs ACOG Comparison

AIRS vs ACOG Comparison

Compare AIRS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

N/A

Current Price

$1.76

Market Cap

182.4M

Sector

Health Care

ML Signal

N/A

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$8.90

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRS
ACOG
Founded
2012
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.4M
193.6M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
AIRS
ACOG
Price
$1.76
$8.90
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$4.50
★ $18.00
AVG Volume (30 Days)
★ 825.3K
89.3K
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.58
EPS
★ N/A
N/A
Revenue
★ $151,818,000.00
$10,220,275.00
Revenue This Year
N/A
$152.34
Revenue Next Year
$2.65
$91.54
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.51
$4.50
52 Week High
$12.00
$10.14

Technical Indicators

Market Signals
Indicator
AIRS
ACOG
Relative Strength Index (RSI) 28.28 56.15
Support Level $1.51 $5.49
Resistance Level $3.31 $9.95
Average True Range (ATR) 0.16 0.47
MACD -0.01 0.01
Stochastic Oscillator 0.00 93.62

Price Performance

Historical Comparison
AIRS
ACOG

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: